D. Evans

发表

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

D. Evans, A. Bode, G. von der Lippe, 2011, European journal of medical research.

The single nucleotide polymorphism −1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

D. Evans, F. Beil, A. Buchwald, 2003, Journal of Molecular Medicine.

Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.

U. Beisiegel, J. de Heer, D. Evans, 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Variation in the gene for human peroxisome proliferator activated receptor γ (PPARγ) does not play a major role in the development of morbid obesity

U. Beisiegel, D. Evans, W. Mann, 2000, International Journal of Obesity.

A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short‐term diet

U. Seedorf, J. Aberle, D. Evans, 2005, Clinical genetics.

A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

J. Aberle, U. Beisiegel, D. Evans, 2001, Journal of Molecular Medicine.

Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans

U. Beisiegel, D. Evans, W. Mann, 2000, International Journal of Obesity.

Lack of association between a human β-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity

U. Beisiegel, D. Evans, A. Wolf, 1999, International Journal of Obesity.

Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.

J. Aberle, D. Evans, F. Beil, 2011, Atherosclerosis.

Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.

J. Aberle, D. Evans, F. Beil, 2011, Atherosclerosis.

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

P. Talmud, Y. Jamshidi, B. Staels, 2000, Diabetologia.

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia

U. Seedorf, D. Evans, F. Beil, 2005, Clinical genetics.

Evidence for an Association between Compound Heterozygosity for Germ Line Mutations in the Hemochromatosis (HFE) Gene and Increased Risk of Colorectal Cancer

D. Bishop, R. Houlston, I. Tomlinson, 2005, Cancer Epidemiology Biomarkers & Prevention.

Association between polymorphisms in candidate genes and morbid obesity

U. Beisiegel, S. Ahle, U. Nellessen, 2001, International Journal of Obesity.

Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.

U. Beisiegel, J. de Heer, D. Evans, 2000, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.

U. Beisiegel, S. Ahle, D. Evans, 1998, Human mutation.